ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 314

Next Generation Sequencing Reveals Restriction of the Treg Cell Repertoire and an Abundance of Shared Synovial Treg Clonotypes in JIA

Lauren A. Henderson1, Stefano Volpi1, Francesco Frugoni2, Susan Kim1, Robert P. Sundel1, Fatma Dedeoglu3, Mindy S. Lo1, Erin Janssen1, Melissa M. Hazen1, Mary Beth Son1, Ronald Mathieu4, David Zurakowski5, Robert C. Fuhlbrigge1, Jolan E. Walter6, Yu Nee Lee1, Peter A. Nigrovic1 and Luigi D Notarangelo7, 1Division of Immunology, Boston Children's Hospital, Boston, MA, 2Immunology, Boston Children's Hospital, Boston, MA, 3Rheumatology, Boston Children's Hospital, Boston, MA, 4Division of Hematology and Oncology, Boston Children's Hospital, Boston, MA, 5Departments of Anesthesia and Surgery, Boston Children’s Hospital, Boston, MA, 6Division of Pediatric Allergy/Immunology, Massachusetts General Hospital for Children, Bpstpm, MA, 7Division of Immunology and The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: T-Regulatory Cells and juvenile arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose Regulatory T cell (Treg) dysfunction has been documented in juvenile idiopathic arthritis (JIA), but the basis for this lapse in suppressive capacity is incompletely understood.  Animal models of autoimmunity demonstrate that a diverse and polyclonal Treg repertoire is essential for immune system homeostasis and Treg cell function.  We therefore employed next generation sequencing (NGS) to analyze the repertoires of synovial fluid (SF) and peripheral blood (PB) Treg and effector T cells (Teff) in JIA. 

Methods Paired SF and PB samples were obtained from patients with JIA.  Control samples included PB from age-matched, healthy children and SF from patients with Lyme arthritis.  Treg (CD4+CD25+CD127lo) and Teff (CD4+CD25–) cells were isolated from SF and PB mononuclear cells by fluorescence-activated cell sorting.  The T cell receptor (TCR) β chain was amplified by multiplex PCR with genomic DNA serving as the template (ImmunoSEQTM).  The PCR products were sequenced using the Illumina HiSeq platform.  Subsequently, the data was analyzed using the ImmunoSEQTM set of online tools, the International ImMunoGeneTics system (IMGT) HighV-QUEST platform, and the Immunoglobulin Analysis Tool (IgAT).  The pre-specified primary aim was to evaluate the clonality of SF and PB Treg and Teff populations in JIA patients.  Based on data evaluating the Treg repertoire and autoimmunity in animal models, we calculated that a sample size of 5 JIA patients would provide sufficient power for this study. 

Results  5 patients with JIA, 3 healthy controls, and 2 patients with Lyme arthritis were studied.  In the PB of controls, the Treg and Teff repertoires were equally polyclonal.  In contrast, JIA PB Treg cells were more clonal than control PB Treg, control PB Teff, and JIA PB Teff cells (ANOVA p<0.0001 with Bonferroni correction).  JIA disease severity, as measured by the active joint count, correlated with the PB Treg clonality (ρ=0.95, p=0.005).  Clonal abnormalities were not observed in the JIA PB Teff repertoire.  In SF, JIA Treg cells were significantly more clonal than JIA PB Treg and Teff cells, JIA SF Teff cells, and control PB Treg and Teff cells (ANOVA p<0.0001with Bonferroni correction).  JIA patients shared a substantial portion of SF Treg clonotypes, significantly more than SF Teff cells (Wilcoxon p=0.0002).  In some JIA patient pairs, up to 19% of SF Treg clonotypes were shared.  Further, these shared SF Treg clonotypes were private to JIA patients and were not identified in Lyme arthritis.  In further support of disease specific TCRs in JIA SF, convergent recombination was seen preferentially in the SF Treg compared to the PB Treg compartment (Wilcoxon p=0.002).  Skewed TCRβ variable family and joining gene usage, including overuse of gene segments that have been associated with other autoimmune conditions, was observed in JIA Treg and Teff cells. 

Conclusion Our data identified an unexpected restriction of the SF and PB Treg repertoires in JIA with sharing of SF Treg clonotypes across arthritis patients.  These findings suggest that inadequacy in the Treg repertoire may contribute to Treg cell dysfunction and the perpetuation of inflammation in JIA, possibly in response to shared antigenic triggers.


Disclosure:

L. A. Henderson,

Adaptive Technologies/Immunoseq,

2;

S. Volpi,
None;

F. Frugoni,
None;

S. Kim,
None;

R. P. Sundel,
None;

F. Dedeoglu,
None;

M. S. Lo,
None;

E. Janssen,
None;

M. M. Hazen,
None;

M. B. Son,
None;

R. Mathieu,
None;

D. Zurakowski,
None;

R. C. Fuhlbrigge,
None;

J. E. Walter,
None;

Y. N. Lee,
None;

P. A. Nigrovic,
None;

L. D. Notarangelo,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/next-generation-sequencing-reveals-restriction-of-the-treg-cell-repertoire-and-an-abundance-of-shared-synovial-treg-clonotypes-in-jia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology